Founders Capital Management Novartis Ag Transaction History

Founders Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 05, 2018	SELL	$66.94 - $77.43 $819,747 - $948,207	-12,246 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$64.91 - $73.36 $1.39 Million - $1.58 Million	-21,474 Reduced 63.68%	12,246 $925,000
Q4 2017 Jan 22, 2018	BUY	$72.33 - $77.64 $4,339 - $4,658	60 Added 0.18%	33,720 $2.83 Million
Q3 2017 Oct 17, 2017	BUY	$74.14 - $77.27 $2.5 Million - $2.6 Million	33,660	33,660 $2.89 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.